AS 403
Alternative Names: AS-403; N-403Latest Information Update: 13 Jan 2023
At a glance
- Originator Amyloid Solution
- Class Antidementias
- Mechanism of Action Glial cell modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Alzheimer's disease
Most Recent Events
- 29 Nov 2022 Early research in Alzheimer's disease in South Korea (unspecified route), before November 2022 (Amyloid solution pipeline, November 2022)